898
Views
11
CrossRef citations to date
0
Altmetric
Short Communication

Toxicity–structure activity evaluation of limonoids from Swietenia species on Artemia salina

, , &
Pages 264-267 | Received 12 Sep 2010, Accepted 13 Apr 2011, Published online: 12 Jan 2012

Abstract

Context: Many plant extracts and compounds are being investigated for their cytotoxicity and hence their medicinal or therapeutic properties. Reports of toxicity studies with limonoid analogs have been sparse and have involved mainly crude extracts. In this study, individual natural limonoids have been isolated and their toxicity manipulated via semisynthesis.

Objective: The lethality of limonoid analogs from Swietenia macrophylla King and Swietenia aubrevilleana Stehlé & Cusin (Meliaceae) against Artemia salina Leach was determined.

Materials and methods: Four known natural limonoids were isolated from the dry ground seeds of S. macrophylla and S. aubrevilleana, modified using acylation and hydrolysis reactions and tested in A. salina lethality assays at 1–400 ppm. A 50% lethal concentration (LC50) was determined by probit analysis.

Results: Higher levels of toxicity were achieved in most of the prepared analogs compared with the parent natural limonoids. The compound showing the highest toxicity with LC50 3.9 ppm was 3-O-benzoyl-3-detigloylisoswietenine (20). Other analogs with high toxicity were 6-O-benzoylswietenolide (7), 6-O-benzoylswietenine (17), and 3,6-O,O-dipropionylswietenolide (9), which showed LC50 values of 4.3, 7.5, and 28.5 ppm, respectively.

Discussion and conclusions: Toxicity can be improved via semisynthesis. The compounds exhibiting high toxicity (low LC50) may be good candidates for cytotoxicity studies.

Introduction

Fifty percent or more of organic compounds introduced as pharmaceutical drugs are derived from natural products (El Sayed, 2002; CitationGhisalberti, 2008) and some have been discovered because of traditional or folk remedies (CitationAlves and Rosa, 2007). Among the plants being investigated for their medicinal properties are species of Meliacae and Rutaceae. For example, the fruit concentrate of Swietenia macrophylla King (Meliaceae) has been used to improve blood circulation and skin condition in Southern Mexico, Central America, and Bolivia (CitationTan et al., 2009); extracts of Swietenia mahogani (L.) Jacq. (Meliaceae), a parent species (CitationPennington et al., 1981) for Swietenia aubrevilleana Stehlé & Cusin (Meliaceae) are used in Indonesia for the treatment of hypertension and diabetes (CitationChen et al., 2007) and Citrus seeds (Rutaceae) are used in traditional Chinese medicine to treat liver diseases and hernia (CitationTian et al., 2001). Phytochemical investigations have revealed limonoids and triterpenoids, in general, to be the major compounds of interest in these Meliaceae and Rutaceae folk medicines, and more recently there is evidence that these compounds may be effective anticancer agents (CitationSetzer and Setzer, 2003; CitationKumar et al., 2010).

The Artemia salina lethality assay is regarded as a useful screening tool for preliminary assessment of toxicity and hence potential cytotoxicity of compounds, which may suggest medicinal or therapeutic effects (CitationCarballo et al., 2002; CitationMoshafi et al., 2009). Some reports of A. salina lethality studies using limonoid analogs have involved extracts from Melia azedarach L. (CitationPisutthanan et al., 2004; CitationFukuyama et al., 2006); nimbolide (from Azadirachta indica A. Juss. (neem) seeds) with an ED50 of 568.7 ppm (CitationGenupur et al., 2006); capensolactone 1 and 2 showing moderate biological activity (CitationMulholland and Lourine, 1998) and the chloroform, methanol, and aqueous extracts of A. indica giving LC50 of 7.5 ppm (CitationBhat et al., 2009). The aim of this research was to document the toxicity of our isolated limonoids from S. macrophylla and S. aubrevilleana using A. salina lethality assays and alter their toxicity by semisynthesis.

Materials and methods

Isolation, semisynthesis, and chemical data

Fruits of S. macrophylla and S. aubrevilleana were collected from the grounds of The University of the West Indies St. Augustine campus in February 1999 (identified by Winston Johnson, National Herbarium of Trinidad and Tobago, 2nd Floor Sir Frank Stockdale Building, Faculty of Science and Agriculture, University of the West Indies, St. Augustine, Trinidad). Voucher specimens are secured by the National Herbarium of Trinidad and Tobago (S. macrophylla 33274 and S. aubrevilleana 33272). Swietenolide (1), 3,6-O,O-diacetylswietenolide (2), swietenine (3), swietemahonin G (4), and 2-hydroxyswietenine (5) () were isolated from the EtOAC extract of the dried seeds (CitationMootoo et al., 1999) using column and plate chromatography, utilizing solvent systems CHCl3–EtOAc, petroleum ether–EtOAc, or petroleum ether–CHCl3–MeOH.

Figure 1.  Structure of compounds used in A. salina Leach toxicity assays.

Figure 1.  Structure of compounds used in A. salina Leach toxicity assays.

The analogs 615, 17, 20–22, 25, and 26 () were prepared from the acylation reactions of compounds 1, 3, 19, and 24 (), respectively. Each compound was dissolved in a minimum of 60 equivalents of pyridine, followed by the addition of minimum 6.3 equivalents of the selected acylating reagent (benzoyl chloride, isovaleryl chloride, isobutyryl chloride, propionic anhydride, or tert-butylacetyl chloride). The reaction mixture was stirred for 18–24 h at 25°C. Reactions with benzoyl chloride, propionyl anhydride, and isobutyryl chloride were refluxed at 40–60°C for an additional 1 h. The reaction mixture was quenched with ice and the suspension extracted with EtOAc. The EtOAc layer was washed with NaHCO3 (1 M) followed by distilled H2O, HCl (0.1 M) and finally distilled H2O. The EtOAc layer was then dried with anhydrous Na2SO4, filtered, evaporated in vacuo to dryness and purified using column and preparative thin layer chromatography and solvent systems CHCl3–EtOAc, petroleum ether–EtOAc, petroleum ether–CHCl3–MeOH, or hexane–EtOAC (CitationFowles et al., 2010).

Compound 16 was prepared by heating compound 1 (0.10 mmol) at 60–70°C for 1.5–2 h then stirring overnight at 25°C in MeOH (10 mL), methanol KOH (50 mL, 0.9 M), and distilled water (50 mL). Compounds 18 and 23 (0.1 mmol) were prepared by refluxing at 60–70°C 3 and 5 in methanol KOH (3: 50 mL, 0.5 M and 5: 50 mL, 0.9 M methanol KOH) and distilled water (50 mL). Compound 4 was stirred in methanol KOH for 3 h at 25°C to give its hydrolyzed product (not isolated). Work up involved cooling the alkaline solutions then acidifying with concentrated HCl to pH 1 (1 and 5), pH 2.5 (3) and pH 4 (4). The acidic solutions were extracted with EtOAC, dried with anhydrous Na2SO4, filtered, and evaporated in vacuo to dryness to give compounds 16, 18, and 23 (). Unreacted starting compounds were removed by dissolving the mixture in CHCl3 and extracting the solution with NaHCO3 (1 M). Methylation of compounds 18, 23, and hydrolyzed product of compound 4 using an ethereal solution of diazomethane gave compounds 19, 24, and 27 (). Analogs were identified using one- and two-dimensional (COSY, HMQC, and HMBC) 1H and 13C NMR, IR, and MS (CitationFowles et al., 2010).

Bioassay

Eggs of A. salina were placed in a vessel partially filled with artificial seawater and incubated at 29°C for 48 h until they hatched. The test compounds (1 mg each) were dissolved in dimethyl sulfoxide (DMSO) (50 μL) and made up to 1 mL with artificial seawater. Serial dilutions (50, 100, 200, 400, 600, and 800 ppm) of each test compound were prepared. The diluted samples (100 μL) were placed in microplate wells (Corning Glass Works, Corning, New York 14831, USA) in triplicates. Control wells comprised DMSO diluted with artificial seawater. Artificial seawater (100 μL) containing 10–15 A. salina nauplii was added to each well and the plate was incubated at 29°C for 24 h (the effective concentrations were therefore 25, 50, 100, 200, 300, and 400 ppm). Plates were examined under a microscope and the number of dead (non-mobile) nauplii in each well counted. Where 100% mortality was observed at 25 ppm, the experiment was repeated with serial dilutions from 25 to 1 ppm. Methanol (100 μL) was then added to each well and the total number of organism in each well counted after 15 min. LC50 values were calculated using probit analysis (CitationFinney, 1971). Statistical analysis was done using the Tukey–Kramer multiple comparison test at a 5% significance level (P = 0.05).

Results

All the synthetic swietenolide (1) derivatives were found to be more toxic than the parent compound (LC50 > 500 ppm). Noted among the derivatives were 6-O-benzoylswietenolide (7) and 3,6-O,O-dipropionylswietenolide (9), which showed low LC50 values (high toxicity) of 4.3 and 28.5 ppm, respectively. Addition of one methyl group to compound 10 caused a decrease in toxicity from LC50 85.0 to 120.9 ppm as seen in 3-O-isobutyrylswietenolide (14), whereas further addition of one methylene group to give 3-O-isovalerylswietenolide (13) increased the toxicity to LC50 73.8 ppm ().

Table 1.  Toxicity (LC50) of compounds 127 against A. salina Leach.

All swietenine (3) derivatives except demethyl-3-detigloylisoswietenine (18) were more toxic than 3, which was not toxic up to 500 ppm (). The introduction of a benzoyl group to the swietenine skeleton to form 6-O-benzoylswietenine (17) increased toxicity significantly to LC50 7.5 ppm. The compound 3-O-benzoyl-3-detigloylisoswietenine (20) was the most toxic with an LC50 of 3.9 ppm although this was not significantly more toxic than either compound 7 or 17. The intermediates in the preparation of 20 were the hydrolysis and methylation compounds demethyl-3-detigloylisoswietenine (18) and 3-detigloylisoswietenine (19). Compound 18 was not toxic up to 500 ppm, whereas 19 gave an LC50 144.0 ppm ().

Compound 5 was not toxic up to 500 ppm and its derivatives generally showed low levels of toxicity. The most toxic derivative was 3,6-O,O-dibenzoyl-3-detigloyl-2-hydroxy isoswietenine (26) with an LC50 of 210.1 ppm ().

Hydrolysis followed by methylation of 4 (LC50 220.1 ppm) resulted in 3-detigloylisoswietemahonin G (27), which was not toxic up to 500 ppm ().

Discussion

Among all the compounds investigated, 3-O-benzoyl-3-detigloylisoswietenine (20) had the lowest LC50 value (3.9 ppm) and was therefore the most toxic compound. Other compounds that showed high toxicity were 6-O-benzoylswietenolide (7) (LC50 4.3 ppm), 6-O-benzoylswietenine (17) (LC50 7.5 ppm) and 3,6-O,O-dipropionylswietenolide (9) (LC50 28.5 ppm). The demethylated compounds 16, 18, and 23 were not toxic up to 500 ppm, similar to their respective starting materials.

Addition of acyl groups, in particular benzoyl groups, generally resulted in higher toxicity than the starting materials with the exception of 3,6-O,O-di-tert-butylacetylswietenolide (15) and 3,6-O,O-diacetylswietenolide (2).

Conclusions

Twenty-seven compounds including natural limonoids were studied in A. salina lethality assays. Most of the semisynthesized analogs showed increased toxicity over their parent compounds. Despite the very high toxicity values in some of the compounds tested against A. salina, the results may indicate that some limonoids are suitable candidates for studies in cytotoxic assays, which will lead to preliminary understanding of the medicinal value of these compounds.

Acknowledgement

We thank Marie Mohammed and Anissa Pierre for assistance with this project.

Declaration of interest

Financial support for this work was provided by the University of the West Indies, St. Augustine Campus.

References

  • Alves RRN, Rosa IML. (2007). Biodiversity, traditional medicine and public health: where do they meet? J Ethnobiol Ethnomed [Online]. Available at: http://www.ethnobiomed.com/content/3/1/14. Accessed on November 15, 2010.
  • Bhat M, Kothiwale SK, Tirmale AR, Bhargava SY, Joshi BN. (2009). Antidiabetic properties of Azardiracta indica and Bougainvillea spectabilis: in vivo studies in murine diabetes model. Evid Based Complement Alternat Med,1–8.
  • Carballo JL, Hernández-Inda ZL, Pérez P, García-Grávalos MD. (2002). A comparison between two brine shrimp assays to detect in vitro cytotoxicity in marine natural products. BMC Biotechnol [Online]. Available at: http://www.biomedcentral.com/1472-6750/2/17. Accessed September 7, 2010.
  • Chen Y, Wang X, Fan C, Yin S, Yue J. (2007). Swiemahogins A and B, two novel limonoids from Swietenia mahogani. Tetrahedron Lett, 48, 7480–7484.
  • El Sayed KA. (2000). Natural products as antiviral agents. Stud Nat Prod Chem Bioactive Nat Prod (Part E), 473–572.
  • Finney DJ. (1971). Probit Analysis. Cambridge, UK: Cambridge University Press.
  • Fowles R, Mootoo B, Ramsewak R, Khan A, Ramsubhag A, Reynolds W, Nair M. (2010). Identification of new limonoids from Swietenia and their biological activity against insects. Pest Manag Sci, 66, 1298–1303.
  • Fukuyama Y, Nakaoka M, Yamamoto T, Takahashi H, Minami H. (2006). Degraded and oxetane-bearing limonoids from the roots of Melia azedarach. Chem Pharm Bull, 54, 1219–1222.
  • Genupur A, Jesu JL, Srinivasan N, Kamalakaran AS, Sundar RS. (2006). Synthesis and cytotoxicity of novel isomeric C-seco limonoids. Eur J Med Chem, 41, 997–1002.
  • Ghisalberti EL. (2008). Detection and isolation of bioactive natural products. In: Molyneux RJ, Colegate SM, eds. Bioactive Natural Products—Detection, Isolation, and Structural Determination. Boca Raton, FL: CRC, pp. 11–76.
  • Kumar GH, Priyadarsini RV, Vinothini G, Letchoumy PV, Nagini S. (2010). The neem limonoids azadirachtin and nimbolide inhibit cell proliferation and induce apoptosis in an animal model of oral oncogenesis. Invest New Drugs, 28, 392–401.
  • Mootoo BS, Ali A, Motilal R, Pingal R, Ramlal A, Khan A, Reynolds WF, McLean S. (1999). Limonoids from Swietenia macrophylla and S. aubrevilleana. J Nat Prod, 62, 1514–1517.
  • Moshafi MH, Sharififar F, Gholam-Reza D, Ameri A. (2009). Bioassay screening of the essential oil and various extracts of fruits of Heracleum persicum Desf. and rhizomes of Zingiber officinale Rosc. using brine shrimp cytotoxicity assay. Iranian J Pharm Res, 8, 59–63.
  • Mulholland DA, Lourine SE. (1998). Limonoids from Ekebergia capensis. Phytochemistry, 47, 1357–1361.
  • Pennington TD, Styles BT, Taylor DAH. (1981). Meliaceae, with Accounts of Swietenioideae and Chemotaxonomy. Bronx, New York: The New York Botanical Garden Press.
  • Pisutthanan S, Plianbangchang P, Pisutthanan N, Ruanruaya S, Muanrita O. (2004). Brine shrimp lethality activity of Thai medicinal plants in the family Meliaceae. Naresuan Univ J, 12, 13–18.
  • Setzer WN, Setzer MC. (2003). Plant-derived triterpenoids as potential antineoplastic agents. Mini Rev Med Chem, 3, 540–556.
  • Tan S, Osman H, Wong K, Boey P. (2009). New phragmalin-type limonoids from Swietenia macrophylla King. Food Chem, 115, 1279–1285.
  • Tian Q, Miller EG, Ahmad H, Tang L, Patil BS. (2001). Differential inhibition of human cancer cell proliferation by citrus limonoids. Nutr Cancer, 40, 180–184.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.